In vitro selection of variants of herpes simplex virus type 1 which differ in cytopathic changes

Microbiol Immunol. 1997;41(3):203-7. doi: 10.1111/j.1348-0421.1997.tb01191.x.

Abstract

To analyze the mechanisms for in vitro emergence of the syncytial variants of herpes simplex virus type 1 (HSV-1), several cell lines were infected with a mixture of equal amounts of two HSV-1 variants, one syncytial and the other non-syncytial, and changes in their relative abundance were monitored during passage. With a combination of two variants of the Miyama strain of HSV-1, the syncytial variant became dominant during passage in Vero, RK-13 and FL cells. On the other hand, the ratios of the two variants remained around 1:1 during the passage in HEp-2, MGC and HEL cells. In another set of variants of the SKO strain of HSV-1, the outcomes were different from those of the Miyama strain in the FL, MGC and HEp-2 cells. The ratios of the two variants remained around 1:1 during passage in FL cells, while the non-syncytial variant became dominant during passage in MGC and HEp-2 cells. In addition, we examined the effects of a complement and interferon-beta (IFN-beta) on the outcome of the selection. As a result, the complement slowed the selection of a syncytial variant, whereas IFN-beta facilitated it.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Complement System Proteins / pharmacology
  • Cytopathogenic Effect, Viral / genetics
  • Genetic Variation*
  • Giant Cells
  • Herpesvirus 1, Human / genetics*
  • Herpesvirus 1, Human / pathogenicity*
  • Interferon-beta / pharmacology
  • Selection, Genetic*
  • Serial Passage
  • Viral Envelope Proteins

Substances

  • Viral Envelope Proteins
  • glycoprotein gC, herpes simplex virus type 1
  • Interferon-beta
  • Complement System Proteins